Diagnostics and Stem Cells Power Productive Portfolios: Kevin DeGeeter

June 3, 2013 New medical tests can be moneymakers for small- and mid-cap companies: They save insurers the pain of paying more to treat maladies and save patients from unnecessary treatments.

http://www.investorideas.com/news/2013/biotech/06032.asp